Global NT Growth Factor Receptor 麻豆原创 Research Report 2023

Publication ID:

PB501233729

Publication Date:

January 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

NT Growth factor receptors, a class of growth factor receptors that bind specifically to neurotrophic factors.There are two classes of nerve growth factor receptors: the low affinity neurotrophin receptors (p75 et al.) and the Trk family of receptors that belong to the receptor tyrosine kinases.
Highlights
The global NT Growth Factor Receptor market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for NT Growth Factor Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for NT Growth Factor Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of NT Growth Factor Receptor include AstraZeneca, Daiichi Sankyo Co., Handel Korea, Ignita Corporation, Loxo Oncology, NETRIS Pharmaceuticals, Inc. and Plexxikon, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for NT Growth Factor Receptor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NT Growth Factor Receptor.
The NT Growth Factor Receptor market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global NT Growth Factor Receptor market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NT Growth Factor Receptor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AstraZeneca
Daiichi Sankyo Co.
Handel Korea
Ignita Corporation
Loxo Oncology
NETRIS Pharmaceuticals, Inc.
Plexxikon
Segment by Type
AZD-7451
DS-6051
LM-22B10
Others
Segment by Application
Hospitals
Clinics
Research Institutes
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NT Growth Factor Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NT Growth Factor Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 NT Growth Factor Receptor 麻豆原创 Overview
1.1 Product Overview and Scope of NT Growth Factor Receptor
1.2 NT Growth Factor Receptor Segment by Type
1.2.1 Global NT Growth Factor Receptor 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 AZD-7451
1.2.3 DS-6051
1.2.4 LM-22B10
1.2.5 Others
1.3 NT Growth Factor Receptor Segment by Application
1.3.1 Global NT Growth Factor Receptor 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.3.5 Others
1.4 Global NT Growth Factor Receptor 麻豆原创 Size Estimates and Forecasts
1.4.1 Global NT Growth Factor Receptor Revenue 2018-2029
1.4.2 Global NT Growth Factor Receptor Sales 2018-2029
1.4.3 Global NT Growth Factor Receptor 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NT Growth Factor Receptor 麻豆原创 Competition by Manufacturers
2.1 Global NT Growth Factor Receptor Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global NT Growth Factor Receptor Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global NT Growth Factor Receptor Average Price by Manufacturers (2018-2023)
2.4 Global NT Growth Factor Receptor Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of NT Growth Factor Receptor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NT Growth Factor Receptor, Product Type & Application
2.7 NT Growth Factor Receptor 麻豆原创 Competitive Situation and Trends
2.7.1 NT Growth Factor Receptor 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest NT Growth Factor Receptor Players 麻豆原创 Share by Revenue
2.7.3 Global NT Growth Factor Receptor 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NT Growth Factor Receptor Retrospective 麻豆原创 Scenario by Region
3.1 Global NT Growth Factor Receptor 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global NT Growth Factor Receptor Global NT Growth Factor Receptor Sales by Region: 2018-2029
3.2.1 Global NT Growth Factor Receptor Sales by Region: 2018-2023
3.2.2 Global NT Growth Factor Receptor Sales by Region: 2024-2029
3.3 Global NT Growth Factor Receptor Global NT Growth Factor Receptor Revenue by Region: 2018-2029
3.3.1 Global NT Growth Factor Receptor Revenue by Region: 2018-2023
3.3.2 Global NT Growth Factor Receptor Revenue by Region: 2024-2029
3.4 North America NT Growth Factor Receptor 麻豆原创 Facts & Figures by Country
3.4.1 North America NT Growth Factor Receptor 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America NT Growth Factor Receptor Sales by Country (2018-2029)
3.4.3 North America NT Growth Factor Receptor Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe NT Growth Factor Receptor 麻豆原创 Facts & Figures by Country
3.5.1 Europe NT Growth Factor Receptor 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe NT Growth Factor Receptor Sales by Country (2018-2029)
3.5.3 Europe NT Growth Factor Receptor Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NT Growth Factor Receptor 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific NT Growth Factor Receptor 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific NT Growth Factor Receptor Sales by Country (2018-2029)
3.6.3 Asia Pacific NT Growth Factor Receptor Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America NT Growth Factor Receptor 麻豆原创 Facts & Figures by Country
3.7.1 Latin America NT Growth Factor Receptor 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America NT Growth Factor Receptor Sales by Country (2018-2029)
3.7.3 Latin America NT Growth Factor Receptor Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa NT Growth Factor Receptor 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa NT Growth Factor Receptor 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa NT Growth Factor Receptor Sales by Country (2018-2029)
3.8.3 Middle East and Africa NT Growth Factor Receptor Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NT Growth Factor Receptor Sales by Type (2018-2029)
4.1.1 Global NT Growth Factor Receptor Sales by Type (2018-2023)
4.1.2 Global NT Growth Factor Receptor Sales by Type (2024-2029)
4.1.3 Global NT Growth Factor Receptor Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global NT Growth Factor Receptor Revenue by Type (2018-2029)
4.2.1 Global NT Growth Factor Receptor Revenue by Type (2018-2023)
4.2.2 Global NT Growth Factor Receptor Revenue by Type (2024-2029)
4.2.3 Global NT Growth Factor Receptor Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global NT Growth Factor Receptor Price by Type (2018-2029)
5 Segment by Application
5.1 Global NT Growth Factor Receptor Sales by Application (2018-2029)
5.1.1 Global NT Growth Factor Receptor Sales by Application (2018-2023)
5.1.2 Global NT Growth Factor Receptor Sales by Application (2024-2029)
5.1.3 Global NT Growth Factor Receptor Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global NT Growth Factor Receptor Revenue by Application (2018-2029)
5.2.1 Global NT Growth Factor Receptor Revenue by Application (2018-2023)
5.2.2 Global NT Growth Factor Receptor Revenue by Application (2024-2029)
5.2.3 Global NT Growth Factor Receptor Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global NT Growth Factor Receptor Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca NT Growth Factor Receptor Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca NT Growth Factor Receptor Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Daiichi Sankyo Co.
6.2.1 Daiichi Sankyo Co. Corporation Information
6.2.2 Daiichi Sankyo Co. Description and Business Overview
6.2.3 Daiichi Sankyo Co. NT Growth Factor Receptor Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Daiichi Sankyo Co. NT Growth Factor Receptor Product Portfolio
6.2.5 Daiichi Sankyo Co. Recent Developments/Updates
6.3 Handel Korea
6.3.1 Handel Korea Corporation Information
6.3.2 Handel Korea Description and Business Overview
6.3.3 Handel Korea NT Growth Factor Receptor Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Handel Korea NT Growth Factor Receptor Product Portfolio
6.3.5 Handel Korea Recent Developments/Updates
6.4 Ignita Corporation
6.4.1 Ignita Corporation Corporation Information
6.4.2 Ignita Corporation Description and Business Overview
6.4.3 Ignita Corporation NT Growth Factor Receptor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ignita Corporation NT Growth Factor Receptor Product Portfolio
6.4.5 Ignita Corporation Recent Developments/Updates
6.5 Loxo Oncology
6.5.1 Loxo Oncology Corporation Information
6.5.2 Loxo Oncology Description and Business Overview
6.5.3 Loxo Oncology NT Growth Factor Receptor Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Loxo Oncology NT Growth Factor Receptor Product Portfolio
6.5.5 Loxo Oncology Recent Developments/Updates
6.6 NETRIS Pharmaceuticals, Inc.
6.6.1 NETRIS Pharmaceuticals, Inc. Corporation Information
6.6.2 NETRIS Pharmaceuticals, Inc. Description and Business Overview
6.6.3 NETRIS Pharmaceuticals, Inc. NT Growth Factor Receptor Sales, Revenue and Gross Margin (2018-2023)
6.6.4 NETRIS Pharmaceuticals, Inc. NT Growth Factor Receptor Product Portfolio
6.6.5 NETRIS Pharmaceuticals, Inc. Recent Developments/Updates
6.7 Plexxikon
6.6.1 Plexxikon Corporation Information
6.6.2 Plexxikon Description and Business Overview
6.6.3 Plexxikon NT Growth Factor Receptor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Plexxikon NT Growth Factor Receptor Product Portfolio
6.7.5 Plexxikon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NT Growth Factor Receptor Industry Chain Analysis
7.2 NT Growth Factor Receptor Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NT Growth Factor Receptor Production Mode & Process
7.4 NT Growth Factor Receptor Sales and 麻豆原创ing
7.4.1 NT Growth Factor Receptor Sales Channels
7.4.2 NT Growth Factor Receptor Distributors
7.5 NT Growth Factor Receptor Customers
8 NT Growth Factor Receptor 麻豆原创 Dynamics
8.1 NT Growth Factor Receptor Industry Trends
8.2 NT Growth Factor Receptor 麻豆原创 Drivers
8.3 NT Growth Factor Receptor 麻豆原创 Challenges
8.4 NT Growth Factor Receptor 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

AstraZeneca
Daiichi Sankyo Co.
Handel Korea
Ignita Corporation
Loxo Oncology
NETRIS Pharmaceuticals, Inc.
Plexxikon

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.